Considerations for Long-Term Users If you plan to use BPC-157 beyond a standard 46 week cycle, consider: Taking extended breaks between cycles Using the lowest effective dose Rotating injection sites to avoid local tissue fatigue or inflammation Monitoring subjective markers of progress and potential side effects (energy, GI symptoms, inflammation, blood pressure) Until clinical data becomes available, long-term safety remains uncertain so the guiding principle should be minimal effective use for specific, time-bound recovery goals
A flat scale at month four at the therapeutic dose, with appetite reduction and lifestyle in place, is a signal that the protocol needs adjustment
This is usually temporary treat the symptom, then reassess
In the HCP-restricted sensitivity analysis, acute myocardial infarction shifted to neutrality (ROR 0.45 [0.191.08]), while angina and myocardial ischemia recorded zero events, rendering their RORs not calculable but heavily underscoring a lack of ischemic safety signals
FAQ: Zepbound and the CWMD Weight Loss Program What is Zepbound